Overview

Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients

Status:
Active, not recruiting
Trial end date:
2025-03-24
Target enrollment:
Participant gender:
Summary
This research is designed as an open-label,non-comparative prospective trial.
Phase:
Phase 2
Details
Lead Sponsor:
University of New Mexico
Treatments:
Azithromycin
Hydroxychloroquine